Seminal
The magazine and atlas of EU-funded researchA new publication from the web and AI team at Scott Charnley

Atlas / Belgium

Research and Innovation Action · Running

ISIDORe II Integrated Services for Infectious Disease Outbreak Research Ii

Coordinator
European Research Infrastructure on Highly Pathogenic Agents, Belgium
Runs
1 June 2026 to 31 May 2029
Status
Running
EU funding
€10.5m
Total cost
€10.5m
Partners
56 organisations in 20 countries
Type
Research and Innovation Action
Grant agreement
101293306

What the project is doing

In the project's own words, from its summary on CORDIS.

ISIDORe II (Integrated Services for Infectious Disease Outbreak Research II) represents the strategic continuation of ISIDORe. Building on its proven capacity to mobilise Europe’s research infrastructures (RIs) for pandemic preparedness and response (PP&R) research, ISIDORe II consolidates the model into a leaner, strategically aligned consortium that enhances agility, coherence, and sustainability. Infectious disease–focused RIs form the operational backbone, ensuring depth in epidemic- and pandemic-relevant science, while transversal RIs provide enabling technologies such as imaging, omics, and structural biology.

This integrated architecture ensures that Europe’s RI landscape delivers high-quality, challenge-driven, and interoperable services. ISIDORe II pursues three overarching missions: (1) deliver excellent RI services for PP&R research and empower users through a curated service catalogue, an interoperable digital platform, and inclusive outreach; (2) amplify impact by enabling scientific excellence, innovation, and data stewardship, accelerating medical countermeasure (MCM) development, embedding FAIR principles, and aligning with European Open Science policies; and (3) anchor the ISIDORe model within the EU and global preparedness ecosystem through coordination with actors such as HERA, ECDC, WHO, and DURABLE, while developing a stakeholder-validated sustainability plan.

By offering a coherent, strategically sharpened model for transnational and virtual access (TNA/VA), ISIDORe II ensures that users benefit from comprehensive support, including ethics, biosafety, and regulatory guidance, alongside interoperable data practices. Its activities generate scientific excellence, policy-relevant evidence, and long-term impact for European and global health security. As the natural continuation of ISIDORe, ISIDORe II transforms a successful pilot into a sustainable cornerstone of the European preparedness and response landscape.

Topics

Who is involved

OrganisationCityCountryRole
European Research Infrastructure on Highly Pathogenic AgentsBruxelles / BrusselBelgiumCoordinator
Biobanks and Biomolecular Resources Research Infrastructure Consortium (bbmri-Eric)GrazAustriaParticipant
Medizinische Universitat GrazGrazAustriaThird party
European Virus Archive AisblIxellesBelgiumParticipant
Katholieke Universiteit LeuvenLeuvenBelgiumThird party
Eidgenoessisches Departement Des InnernBernSwitzerlandParticipant
Vaccine Formulation Institute(ch)ltdPlan Les OuatesSwitzerlandParticipant
Ceske Vysoke Uceni Technicke V PrazePrahaCzechiaThird party
Ustav Molekularni Genetiky Av Cr V.v.i.Praha 4CzechiaThird party
Bernhard-Nocht-Institut Fuer TropenmedizinHamburgGermanyThird party
Charite - Universitaetsmedizin BerlinBerlinGermanyThird party
European Infrastructure of Open Screening Platforms for Chemical Biology European Research Infrastucture Consortium (eu-Openscreen Eric)BerlinGermanyParticipant
European Molecular Biology LaboratoryHeidelbergGermanyParticipant
European Vaccine Initiative eVHeidelbergGermanyParticipant
Friedrich Loeffler Institut - Bundesforschungsinstitut Fuer TiergesundheitGreifswald-Insel RiemsGermanyParticipant
Helmholtz-Zentrum Fur Infektionsforschung GmbHBraunschweigGermanyParticipant
Infrafrontier EricNeuherbergGermanyParticipant
Statens Serum InstitutKobenhavn SDenmarkParticipant
Hellenic Pasteur InstituteAthensGreeceThird party
Agencia Estatal Consejo Superior De Investigaciones CientificasMadridSpainThird party
Fundacion Centro De Excelencia En Investigacion De Medicamentos Innovadores En AndaluciaArmilla GranadaSpainThird party
Institut De Investigacio En Ciencies De La Salut Germans Trias I PujolBadalona BarcelonaSpainThird party
Institut De Recerca I Tecnologia AgroalimentariesCaldes De Montbui BarcelonaSpainParticipant
Euro-Bioimaging EricTurkuFinlandParticipant
Helsingin YliopistoHelsinkiFinlandThird party
Assistance Publique Hopitaux De ParisParisFranceParticipant
Centre National De La Recherche Scientifique CNRSParisFranceThird party
Ecrin European Clinical Research Infrastructure NetworkParisFranceParticipant
Institut National De La Sante Et De La Recherche MedicaleParisFranceThird party
Institut National De Recherche Pour L'agriculture, L'alimentation Et L'environnementParisFranceParticipant
Institut PasteurParisFranceThird party
Mediterranee InfectionMarseilleFranceParticipant
Universite D'aix MarseilleMarseilleFranceThird party
Nemzeti Nepegeszsegugyi Es Gyogyszereszeti KozpontBudapestHungaryThird party
Consiglio Nazionale Delle RicercheRomaItalyThird party
Istituto Nazionale per Le Malattie Infettive Lazzaro Spallanzani-Istituto Di Ricovero E Cura a Carattere ScientificoRomaItalyThird party
Istituto Superiore Di SanitaRomaItalyThird party
Istituto Zooprofilattico Sperimentale Della Lombardia E Dell'emilia Romagna Bruno UbertiniBresciaItalyThird party
Istituto Zooprofilattico Sperimentale Delle VenezieLegnaroItalyThird party
Valsts zinatniskais instituts ""Nacionalais petniecibas un inovaciju instituts""""RigaLatviaThird party
Eatris EricAmsterdamNetherlandsParticipant
Erasmus Universitair Medisch Centrum RotterdamRotterdamNetherlandsThird party
Rijksinstituut Voor Volksgezondheid En Milieu (rivm)BilthovenNetherlandsThird party
Stichting Biomedical Primate Research CenterRijswijk ZhNetherlandsParticipant
Stichting Wageningen ResearchWageningenNetherlandsParticipant
Universitetet I Tromsoe - Norges Arktiske UniversitetTromsoNorwayThird party
Fundacao Gimm - Gulbenkian Institute for Molecular MedicineLisboaPortugalThird party
Instituto De Biologia Experimental E TecnologicaOeirasPortugalParticipant
Instituto Nacional De Saude Dr. Ricardo JorgeLisboaPortugalThird party
FolkhalsomyndighetenSolnaSwedenThird party
Karolinska InstitutetStockholmSwedenThird party
Univerza V LjubljaniLjubljanaSloveniaThird party
Biomedicinske Centrum Slovenskej Akademie Vied, Verejna Vyskumna InstituciaBratislavaSlovakiaThird party
Department of HealthLeedsUnited KingdomThird party
Instruct-EricOxfordUnited KingdomParticipant
The Chancellor, Masters and Scholars of the University of OxfordOxfordUnited KingdomThird party

Source: CORDIS, European Commission. Data of 5 Nov 2026, reused under the Commission's reuse policy. View on CORDIS · Grant DOI